PathWest Laboratory Medicine Western Australia, Nedlands, Western Australia, Australia.
CSIRO Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.
PLoS Negl Trop Dis. 2022 Nov 21;16(11):e0010754. doi: 10.1371/journal.pntd.0010754. eCollection 2022 Nov.
A fatal case of Japanese encephalitis (JE) occurred in a resident of the Tiwi Islands, in the Northern Territory of Australia in February 2021, preceding the large JE outbreak in south-eastern Australia in 2022. This study reports the detection, whole genome sequencing and analysis of the virus responsible (designated JEV/Australia/NT_Tiwi Islands/2021).
Reverse transcription quantitative PCR (RT-qPCR) testing was performed on post-mortem brain specimens using a range of JE virus (JEV)-specific assays. Virus isolation from brain specimens was attempted by inoculation of mosquito and mammalian cells or embryonated chicken eggs. Whole genome sequencing was undertaken using a combination of Illumina next generation sequencing methodologies, including a tiling amplicon approach. Phylogenetic and selection analyses were performed using alignments of the Tiwi Islands JEV genome and envelope (E) protein gene sequences and publicly available JEV sequences.
Virus isolation was unsuccessful and JEV RNA was detected only by RT-qPCR assays capable of detecting all JEV genotypes. Phylogenetic analysis revealed that the Tiwi Islands strain is a divergent member of genotype IV (GIV) and is closely related to the 2022 Australian outbreak virus (99.8% nucleotide identity). The Australian strains share highest levels of nucleotide identity with Indonesian viruses from 2017 and 2019 (96.7-96.8%). The most recent common ancestor of this Australian-Indonesian clade was estimated to have emerged in 2007 (95% HPD range: 1998-2014). Positive selection was detected using two methods (MEME and FEL) at several sites in the E and non-structural protein genes, including a single site in the E protein (S194N) unique to the Australian GIV strains.
This case represents the first detection of GIV JEV acquired in Australia, and only the second confirmed fatal human infection with a GIV JEV strain. The close phylogenetic relationship between the Tiwi Islands strain and recent Indonesian viruses is indicative of the origin of this novel GIV lineage, which we estimate has circulated in the region for several years prior to the Tiwi Islands case.
2021 年 2 月,澳大利亚北领地提维群岛的一名居民感染了日本脑炎(JE),导致了 2022 年澳大利亚东南部的大规模 JE 爆发。本研究报告了病毒的检测、全基因组测序和分析(指定为 JEV/Australia/NT_Tiwi Islands/2021)。
使用一系列 JE 病毒(JEV)特异性检测方法对死后脑组织标本进行逆转录定量 PCR(RT-qPCR)检测。尝试通过接种蚊子和哺乳动物细胞或鸡胚进行病毒分离。使用 Illumina 下一代测序方法组合,包括平铺扩增子方法进行全基因组测序。使用 Tiwi 群岛 JEV 基因组和包膜(E)蛋白基因序列以及公开的 JEV 序列的对齐进行系统发育和选择分析。
病毒分离不成功,仅通过能够检测所有 JEV 基因型的 RT-qPCR 检测到 JEV RNA。系统发育分析表明,提维群岛株是基因型 IV(GIV)的一个离散成员,与 2022 年澳大利亚爆发的病毒密切相关(99.8%核苷酸同一性)。澳大利亚株与 2017 年和 2019 年印度尼西亚病毒的核苷酸同一性最高(96.7-96.8%)。该澳大利亚-印度尼西亚进化枝的最近共同祖先估计于 2007 年出现(95%HPD 范围:1998-2014)。使用 MEME 和 FEL 两种方法在 E 和非结构蛋白基因中的几个位点检测到正选择,包括 E 蛋白中一个独特的澳大利亚 GIV 株的单点(S194N)。
该病例代表了在澳大利亚首次检测到 GIV JEV 的病例,也是仅有的第二例经证实的 GIV JEV 株致命性人类感染病例。提维群岛株与最近的印度尼西亚病毒之间的密切系统发育关系表明,这种新型 GIV 谱系起源于该地区,在提维群岛病例之前已经在该地区流行了几年。